Cargando…
Extreme Secretion of PTHrP From a Pancreatic Neuroendocrine Tumor, A Shift From Severe Hypercalcemia to Hypocalcemia
Background: PTHrP-secreting pancreatic neuroendocrine tumors (PNET) are a recognized cause of malignancy associated hypercalcemia. Herein, we report a case of severe hypercalcemia due to an extreme elevation of PTHrP from a PNET, where after treatment of the hypercalcemia, symptomatic hypocalcemia o...
Autores principales: | Nachawi, Noura, Paredes, Stephania, Seibert, Stephen, McShane, Adam, Pantalone, Kevin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089201/ http://dx.doi.org/10.1210/jendso/bvab048.391 |
Ejemplares similares
-
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020) -
SAT-493 A Case of Endometrial Adenocarcinoma Presenting with PTHrP-Mediated Hypercalcemia
por: Weaver, Anne, et al.
Publicado: (2019) -
SAT-346 Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine
por: Panvelker, Samir S, et al.
Publicado: (2020) -
PSAT208 A Case of Hypercalcemia From PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2022) -
SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma
por: Pulipati, Vishnu Priya, et al.
Publicado: (2019)